Abstract

Aims

Dynamic stress computed tomography (CT) perfusion is a non-invasive method for quantifying myocardial ischaemia by assessing myocardial blood flow (MBF). In this meta-analysis, we evaluated the diagnostic accuracy of dynamic CT perfusion for the detection of significant coronary artery disease (CAD) across various CT scanners, obese patients, and its prognostic value.

Methods and results

We systematically searched PubMed, Embase, Web of Science, and Cochrane library for published studies evaluating the accuracy of CT myocardial perfusion in diagnosing functional significant ischaemia by invasive fractional flow reserve. The diagnostic performance of dynamic CT perfusion in detecting ischaemia was evaluated using a summary receiver operating characteristic (sROC) curve. A total of 23 studies underwent meta-analysis. In myocardial region without ischaemia, MBF was measured at 1.39 mL/min/g [95% confidence interval (CI) 1.25–1.54], while in region with ischaemia, it was 0.92 mL/min/g (95% CI 0.83–1.01) (P < 0.001). On the patient-based analysis, the area under the sROC curve of CT-MBF was 0.92, with a sensitivity of 0.82 and specificity of 0.86. Differences in CT type (dual source vs. single source), and body mass index did not significantly affect the diagnostic performance. The pooled hazard ratio of dynamic CT perfusion for predicting adverse events was 4.98 (95% CI 2.08–11.93, P ≤ 0.001, I2 = 61%, P for heterogeneity = 0.07).

Conclusion

Dynamic CT perfusion has high diagnostic performance in the quantitative assessment of ischaemia and detection of functional myocardial ischaemia as defined by invasive FFR and may be useful in risk stratification of CAD patients.

Introduction

Coronary artery disease (CAD) stands as the third most prevalent cause of mortality globally and necessitates conquering.1 Besides assessing the anatomical stenosis of the coronary arteries, functional evaluation, specifically myocardial ischaemia, assumes significance in formulating treatment strategies for CAD. At present, single-photon emission computed tomography (SPECT) represents the most widely employed non-invasive imaging modality for evaluating myocardial ischaemia.2,3 However, the assessment of myocardial ischaemia via cardiac computed tomography (CT) has recently garnered considerable attention.4,5 Dynamic perfusion CT utilizing contrast material allows for a quantitative evaluation of myocardial ischaemia in terms of myocardial blood flow (MBF).6 A primary advantage of dynamic perfusion CT lies in its capacity to simultaneously evaluate coronary artery anatomy, thereby enabling an accurate assessment of the culprit lesion. Moreover, dynamic perfusion CT has demonstrated its potential in predicting future cardiovascular events in cases involving severe myocardial ischaemia and is anticipated to serve as a valuable tool in risk stratification for CAD.7 A recent meta-analysis conducted a comprehensive evaluation of the ability of dynamic perfusion CT to identify significant coronary artery stenosis based on MBF and reported exceedingly high diagnostic performance.8 However, several important clinical questions remain unanswered in this literature, including the comparison of the diagnostic performance of different CT scanners, particularly single source CT (SSCT) and dual source CT (DSCT), the influence of patient body size, and the prognostic ability of CTP. To clarify these questions, we performed a comprehensive meta-analysis of dynamic perfusion CT.

Methods

Search strategy and selection criteria

We employed the methodology proposed by the Cochrane Collaboration and adhered to the reporting criteria outlined in the 2020 guideline Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA).9 Database searches were conducted on 2 June 2023, utilizing PubMed, Web of Science Core Collection, Cochrane advanced search, and the EMBASE electronic database. The following terms were used as keywords: dynamic myocardial perfusion CT, dynamic CT perfusion, CAD, myocardial infarction, and diagnostic accuracy etc. (see Supplementary data online, Material  S1). After screening all titles and abstracts within the search results, two reviewers (S.K. and Y.K.) thoroughly examined the potentially relevant studies for eligibility. Any disparities were resolved by a third reviewer. The study protocol was registered with the University Medical Information Network (registration number: UMIN000051223). Institutional review board approval was not required because the study was a meta-analysis and did not include clinical patient data. Both prospective and retrospective studies using invasive fractional flow reserve (FFR) as a reference criterion for ischaemia were included in this meta-analysis. Studies using significant stenosis on quantitative coronary angiography as a reference criterion were excluded. Literature including case reports, animal studies, and non-English language articles were excluded.

Outcome assessment

Two reviewers, Y.K. and S.K., conducted the extraction of the following study characteristics from the articles: author name, year of publication, country, patient disease, age, gender, BMI, type of CT scanner (SSCT vs. DSCT), CT-MBF values, and other relevant CT parameters. The ability to detect functionally significant coronary stenosis, defined as FFR <0.75 or <0.80, was evaluated in patient- and vessel-based analysis. A meta-analysis was performed using summary receiver operating characteristic (sROC) analysis for (i) CT angiography (CTA) alone, (ii) dynamic CTP alone, and (iii) CTA + CTP combination. Pooled sensitivity and specificity were also calculated. In the vessel-based analysis, sub-analysis was performed for differences in the type of CT device used (SSCT vs. DSCT) and BMI (<25 kg/m² vs. ≥25 kg/m²). The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was employed to evaluate the risk of bias10 (see Supplementary data online, Material S2). In terms of prognostic evaluation, the hazard ratios predicting cardiovascular events during the follow-up period after CT imaging were examined.

Data integration and statistical analysis

Meta-analysis was performed utilizing RevMan 5.41 (Cochrane Collaboration, London, UK) and R Statistical Software (v3.5.1, Boston, MA, USA). A random-effects model was employed to estimate pooled CT-MBF values, and the inverse variance method was utilized to assign weights to each study in the meta-analysis. A summary ROC curve was constructed to evaluate the diagnostic value of dynamic CT perfusion in detecting significant coronary artery stenosis.11 Inverse variance and random-effects models were also employed for integrating hazard ratios. Heterogeneity was assessed using the I2 statistic, where 0% indicates no heterogeneity and 100% suggests strong heterogeneity.12 A significance level of P < 0.05 was considered statistically significant.

Results

A flowchart of the study selection process is shown in Figure 1. Finally, a total of 23 studies were analysed. Characteristics of included studies were summarized in Tables 1 and 2. Twenty studies presented diagnostic performance using FFR as the reference standard,5,7,13–30 and three studies presented data on prognostic value of dynamic CTP.31–33 The total number of patients included in the analysis was 2,190, which included patients with known CAD as well as those with suspected CAD. The countries of publication were as follows: five from China,20,21,28–30 five from Japan,7,19,23,27,32 four from the USA,5,13,31,33 three from the UK16,25,26 and the Netherlands,14,15,18 two from Germany,17,22 and one from Italy.24 Study designs included 12 prospective single-centre studies,13,14,16–20,24,26,28–30 7 prospective multicentre studies,5,7,15,22,25,31,33 and 4 retrospective single-centre studies.21,23,27,32 The type of CT used was SSCT in 4 studies17,19,23,27 and DSCT in 19 studies.5,7,13–16,18,20–22,24–26,28–33

Preferred reporting items for systematic reviews and meta-analyses flow diagram.
Figure 1

Preferred reporting items for systematic reviews and meta-analyses flow diagram.

Table 1

Characteristics of studies included

Author_yearCountryStudy designN of patientAge (years)Male, %Inclusion criteriaBMIBaseline HRStress HRPrevious MI (%)Previous PCI/CABG (%)DM (%)HT (%)DLP (%)Smoker (%)Family history of CAD (%)
Bamberg_2011USAProspective single centre3368.1 ± 10N/ACADN/A72.2 ± 1783.1 ± 16N/A5824855527N/A
Coenen_2017NetherlandsProspective single centre4362.6 ± 8.784CAD20.1 ± 2.363.4 ± 12.983.0 ± 13.7191216634740N/A
Coenen_2017_2NetherlandsProspective multicentre7460.9 ± 9.184CAD26.9 ± 3.6N/AN/A11372054614537
Huber_2013GermanyProspective single centre3263 ± 866suspected CADN/AN/AN/A3N/A1934418116
Kitagawa_2021JapanProspective multi centre15766.5 ± 10.471AP24.6 ± 4.0N/AN/A12313071584410
Knegt_2021UKProspective single centre9356 ± 1080suspected CAD29 ± 568 ± 1191 ± 15N/AN/A3157816246
Kono_2014NetherlandsProspective single centre4262.3 ± 8.781suspected or known CAD26.2 ± 2.662.3 ± 8.7N/AN/AN/A16.752.442.923.842.9
Kuwahara_2020JapanProspective single centre2769.3 ± 8.374%CAD23.9 ± 3.6N/AN/AN/AN/A4462446715
Li_2021ChinaProspective single centre6265.0 ± 10.187.1suspected CAD24.95 ± 3.0670.0 ± 10.184.4 ± 12.3N/A6245.287.143.551.6N/A
Lyu_2022ChinaProspective single centre5138 ± 11.569No CAD22.7 ± 2.677 ± 12100 ± 11N/AN/AN/AN/AN/AN/A8
Meinel_2017USAProspective multicentreprospective multi centre1446177.1suspected or known CADN/AN/AN/AN/AN/A28.556.364.634.7
Michallek_2022GermanyProspective multicentre12766.0 ± 10.872CAD24.8 ± 4.0N/AN/AN/AN/A276250358
Nakamura_2020JapanRetrospective single centre54068 ± 9.165Known or suspected CAD24.0 ± 3.7N/AN/A20333369621519
Nishiyama_2019JapanRetrospective single centre3869.9 ± 8.671CAD24.0 ± 3.5N/AN/AN/AN/A3458505532
Nous_2022USAProspective multicentre11464 ± 866stable CAD26 ± 466 ± 982 ± 11N/AN/A1971735452
Pontone_2019ItalyProspective single centre8564.6 ± 8.279suspected CAD26.7 ± 4.8N/AN/AN/AN/A1977694660
Rossi_2014UKProspective multicentre8060 ± 1079suspected CAD27 ± 466 ± 1187 ± 14N/AN/A1648532635
Rossi_2017UKProspective single centre11557 ± 977Acute coronary syndrome29 ± 568 ± 1191 ± 15N/AN/A3457826343
Tanabe_2020JapanProspective single centre3971.5 (6.8)69obstructive CAD23.6 ± 3.6N/AN/AN/AN/A4156514928
van Assen_2019USAProspective multicentre8160.2 (9.8)72.8CADN/AN/AN/AN/A1627.248.144.430.922.2
Yang_2020ChinaProspective single centre8258.5 ± 1059.8CAD24.7 ± 4.9N/AN/AN/AN/A29.382.963.454.919.5
Yi_2020Chinaprospective single center6061.38 ± 8.0171.67known or suspected CAD26.10 ± 3.75N/AN/AN/AN/A33.3371.6766.6766.6745
Yi_2021Chinaprospective single centre7163.6 ± 8.860.5CAD25.6 ± 3.7N/AN/AN/AN/A63.480.36960.639.4
Author_yearCountryStudy designN of patientAge (years)Male, %Inclusion criteriaBMIBaseline HRStress HRPrevious MI (%)Previous PCI/CABG (%)DM (%)HT (%)DLP (%)Smoker (%)Family history of CAD (%)
Bamberg_2011USAProspective single centre3368.1 ± 10N/ACADN/A72.2 ± 1783.1 ± 16N/A5824855527N/A
Coenen_2017NetherlandsProspective single centre4362.6 ± 8.784CAD20.1 ± 2.363.4 ± 12.983.0 ± 13.7191216634740N/A
Coenen_2017_2NetherlandsProspective multicentre7460.9 ± 9.184CAD26.9 ± 3.6N/AN/A11372054614537
Huber_2013GermanyProspective single centre3263 ± 866suspected CADN/AN/AN/A3N/A1934418116
Kitagawa_2021JapanProspective multi centre15766.5 ± 10.471AP24.6 ± 4.0N/AN/A12313071584410
Knegt_2021UKProspective single centre9356 ± 1080suspected CAD29 ± 568 ± 1191 ± 15N/AN/A3157816246
Kono_2014NetherlandsProspective single centre4262.3 ± 8.781suspected or known CAD26.2 ± 2.662.3 ± 8.7N/AN/AN/A16.752.442.923.842.9
Kuwahara_2020JapanProspective single centre2769.3 ± 8.374%CAD23.9 ± 3.6N/AN/AN/AN/A4462446715
Li_2021ChinaProspective single centre6265.0 ± 10.187.1suspected CAD24.95 ± 3.0670.0 ± 10.184.4 ± 12.3N/A6245.287.143.551.6N/A
Lyu_2022ChinaProspective single centre5138 ± 11.569No CAD22.7 ± 2.677 ± 12100 ± 11N/AN/AN/AN/AN/AN/A8
Meinel_2017USAProspective multicentreprospective multi centre1446177.1suspected or known CADN/AN/AN/AN/AN/A28.556.364.634.7
Michallek_2022GermanyProspective multicentre12766.0 ± 10.872CAD24.8 ± 4.0N/AN/AN/AN/A276250358
Nakamura_2020JapanRetrospective single centre54068 ± 9.165Known or suspected CAD24.0 ± 3.7N/AN/A20333369621519
Nishiyama_2019JapanRetrospective single centre3869.9 ± 8.671CAD24.0 ± 3.5N/AN/AN/AN/A3458505532
Nous_2022USAProspective multicentre11464 ± 866stable CAD26 ± 466 ± 982 ± 11N/AN/A1971735452
Pontone_2019ItalyProspective single centre8564.6 ± 8.279suspected CAD26.7 ± 4.8N/AN/AN/AN/A1977694660
Rossi_2014UKProspective multicentre8060 ± 1079suspected CAD27 ± 466 ± 1187 ± 14N/AN/A1648532635
Rossi_2017UKProspective single centre11557 ± 977Acute coronary syndrome29 ± 568 ± 1191 ± 15N/AN/A3457826343
Tanabe_2020JapanProspective single centre3971.5 (6.8)69obstructive CAD23.6 ± 3.6N/AN/AN/AN/A4156514928
van Assen_2019USAProspective multicentre8160.2 (9.8)72.8CADN/AN/AN/AN/A1627.248.144.430.922.2
Yang_2020ChinaProspective single centre8258.5 ± 1059.8CAD24.7 ± 4.9N/AN/AN/AN/A29.382.963.454.919.5
Yi_2020Chinaprospective single center6061.38 ± 8.0171.67known or suspected CAD26.10 ± 3.75N/AN/AN/AN/A33.3371.6766.6766.6745
Yi_2021Chinaprospective single centre7163.6 ± 8.860.5CAD25.6 ± 3.7N/AN/AN/AN/A63.480.36960.639.4

BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DLP, dyslipidaemia; DM, diabetes mellitus; HR, heart rate; HT, hypertension; N/A, not applicable; MI, myocardial infarction; PCI, percutaneous coronary intervention; SD, standard deviation.

Table 1

Characteristics of studies included

Author_yearCountryStudy designN of patientAge (years)Male, %Inclusion criteriaBMIBaseline HRStress HRPrevious MI (%)Previous PCI/CABG (%)DM (%)HT (%)DLP (%)Smoker (%)Family history of CAD (%)
Bamberg_2011USAProspective single centre3368.1 ± 10N/ACADN/A72.2 ± 1783.1 ± 16N/A5824855527N/A
Coenen_2017NetherlandsProspective single centre4362.6 ± 8.784CAD20.1 ± 2.363.4 ± 12.983.0 ± 13.7191216634740N/A
Coenen_2017_2NetherlandsProspective multicentre7460.9 ± 9.184CAD26.9 ± 3.6N/AN/A11372054614537
Huber_2013GermanyProspective single centre3263 ± 866suspected CADN/AN/AN/A3N/A1934418116
Kitagawa_2021JapanProspective multi centre15766.5 ± 10.471AP24.6 ± 4.0N/AN/A12313071584410
Knegt_2021UKProspective single centre9356 ± 1080suspected CAD29 ± 568 ± 1191 ± 15N/AN/A3157816246
Kono_2014NetherlandsProspective single centre4262.3 ± 8.781suspected or known CAD26.2 ± 2.662.3 ± 8.7N/AN/AN/A16.752.442.923.842.9
Kuwahara_2020JapanProspective single centre2769.3 ± 8.374%CAD23.9 ± 3.6N/AN/AN/AN/A4462446715
Li_2021ChinaProspective single centre6265.0 ± 10.187.1suspected CAD24.95 ± 3.0670.0 ± 10.184.4 ± 12.3N/A6245.287.143.551.6N/A
Lyu_2022ChinaProspective single centre5138 ± 11.569No CAD22.7 ± 2.677 ± 12100 ± 11N/AN/AN/AN/AN/AN/A8
Meinel_2017USAProspective multicentreprospective multi centre1446177.1suspected or known CADN/AN/AN/AN/AN/A28.556.364.634.7
Michallek_2022GermanyProspective multicentre12766.0 ± 10.872CAD24.8 ± 4.0N/AN/AN/AN/A276250358
Nakamura_2020JapanRetrospective single centre54068 ± 9.165Known or suspected CAD24.0 ± 3.7N/AN/A20333369621519
Nishiyama_2019JapanRetrospective single centre3869.9 ± 8.671CAD24.0 ± 3.5N/AN/AN/AN/A3458505532
Nous_2022USAProspective multicentre11464 ± 866stable CAD26 ± 466 ± 982 ± 11N/AN/A1971735452
Pontone_2019ItalyProspective single centre8564.6 ± 8.279suspected CAD26.7 ± 4.8N/AN/AN/AN/A1977694660
Rossi_2014UKProspective multicentre8060 ± 1079suspected CAD27 ± 466 ± 1187 ± 14N/AN/A1648532635
Rossi_2017UKProspective single centre11557 ± 977Acute coronary syndrome29 ± 568 ± 1191 ± 15N/AN/A3457826343
Tanabe_2020JapanProspective single centre3971.5 (6.8)69obstructive CAD23.6 ± 3.6N/AN/AN/AN/A4156514928
van Assen_2019USAProspective multicentre8160.2 (9.8)72.8CADN/AN/AN/AN/A1627.248.144.430.922.2
Yang_2020ChinaProspective single centre8258.5 ± 1059.8CAD24.7 ± 4.9N/AN/AN/AN/A29.382.963.454.919.5
Yi_2020Chinaprospective single center6061.38 ± 8.0171.67known or suspected CAD26.10 ± 3.75N/AN/AN/AN/A33.3371.6766.6766.6745
Yi_2021Chinaprospective single centre7163.6 ± 8.860.5CAD25.6 ± 3.7N/AN/AN/AN/A63.480.36960.639.4
Author_yearCountryStudy designN of patientAge (years)Male, %Inclusion criteriaBMIBaseline HRStress HRPrevious MI (%)Previous PCI/CABG (%)DM (%)HT (%)DLP (%)Smoker (%)Family history of CAD (%)
Bamberg_2011USAProspective single centre3368.1 ± 10N/ACADN/A72.2 ± 1783.1 ± 16N/A5824855527N/A
Coenen_2017NetherlandsProspective single centre4362.6 ± 8.784CAD20.1 ± 2.363.4 ± 12.983.0 ± 13.7191216634740N/A
Coenen_2017_2NetherlandsProspective multicentre7460.9 ± 9.184CAD26.9 ± 3.6N/AN/A11372054614537
Huber_2013GermanyProspective single centre3263 ± 866suspected CADN/AN/AN/A3N/A1934418116
Kitagawa_2021JapanProspective multi centre15766.5 ± 10.471AP24.6 ± 4.0N/AN/A12313071584410
Knegt_2021UKProspective single centre9356 ± 1080suspected CAD29 ± 568 ± 1191 ± 15N/AN/A3157816246
Kono_2014NetherlandsProspective single centre4262.3 ± 8.781suspected or known CAD26.2 ± 2.662.3 ± 8.7N/AN/AN/A16.752.442.923.842.9
Kuwahara_2020JapanProspective single centre2769.3 ± 8.374%CAD23.9 ± 3.6N/AN/AN/AN/A4462446715
Li_2021ChinaProspective single centre6265.0 ± 10.187.1suspected CAD24.95 ± 3.0670.0 ± 10.184.4 ± 12.3N/A6245.287.143.551.6N/A
Lyu_2022ChinaProspective single centre5138 ± 11.569No CAD22.7 ± 2.677 ± 12100 ± 11N/AN/AN/AN/AN/AN/A8
Meinel_2017USAProspective multicentreprospective multi centre1446177.1suspected or known CADN/AN/AN/AN/AN/A28.556.364.634.7
Michallek_2022GermanyProspective multicentre12766.0 ± 10.872CAD24.8 ± 4.0N/AN/AN/AN/A276250358
Nakamura_2020JapanRetrospective single centre54068 ± 9.165Known or suspected CAD24.0 ± 3.7N/AN/A20333369621519
Nishiyama_2019JapanRetrospective single centre3869.9 ± 8.671CAD24.0 ± 3.5N/AN/AN/AN/A3458505532
Nous_2022USAProspective multicentre11464 ± 866stable CAD26 ± 466 ± 982 ± 11N/AN/A1971735452
Pontone_2019ItalyProspective single centre8564.6 ± 8.279suspected CAD26.7 ± 4.8N/AN/AN/AN/A1977694660
Rossi_2014UKProspective multicentre8060 ± 1079suspected CAD27 ± 466 ± 1187 ± 14N/AN/A1648532635
Rossi_2017UKProspective single centre11557 ± 977Acute coronary syndrome29 ± 568 ± 1191 ± 15N/AN/A3457826343
Tanabe_2020JapanProspective single centre3971.5 (6.8)69obstructive CAD23.6 ± 3.6N/AN/AN/AN/A4156514928
van Assen_2019USAProspective multicentre8160.2 (9.8)72.8CADN/AN/AN/AN/A1627.248.144.430.922.2
Yang_2020ChinaProspective single centre8258.5 ± 1059.8CAD24.7 ± 4.9N/AN/AN/AN/A29.382.963.454.919.5
Yi_2020Chinaprospective single center6061.38 ± 8.0171.67known or suspected CAD26.10 ± 3.75N/AN/AN/AN/A33.3371.6766.6766.6745
Yi_2021Chinaprospective single centre7163.6 ± 8.860.5CAD25.6 ± 3.7N/AN/AN/AN/A63.480.36960.639.4

BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DLP, dyslipidaemia; DM, diabetes mellitus; HR, heart rate; HT, hypertension; N/A, not applicable; MI, myocardial infarction; PCI, percutaneous coronary intervention; SD, standard deviation.

Table 2

Summary of diagnostic performance of CT-MBF in included studies

Author_YearReferenceOptimal MBF cut-off value (mL/min/g)TPFPFNTNAUCAUC 95% CI upper limitAUC 95% CI lower limit
Bamberg_2011FFR0.75279258N/AN/AN/A
Coenen_2017FFR0.76361012360.780.870.67
Coenen_2017_2FFR0.91491218630.85N/AN/A
Huber_2013FFR1.642207670.860.920.77
Kitagawa_2021FFR1.168292302380.840.800.87
Knegt_2021FFR0.72411981500.8629090.806
Kono_2014FFR1.0344141320.87N/AN/A
Kuwahara_2020FFR1.703742380.940.990.77
Li_2021FFR0.894932410.956N/AN/A
Lyu_2022FFR1.16170628610.8710.9260.817
Michallek_2022FFR1.16713182250.90.940.85
Nishiyama_2019FFR1.261737870.960.980.9
Nous_2022FFRN/A6223121920.790.860.71
Pontone_2019FFR1.015616151450.9190.9540.883
Rossi_2014FFR0.78491391570.950.980.92
Rossi_2017FFR1.145425181890.870.920.83
Tanabe_2020FFR1.25287532N/AN/AN/A
Yang_2020FFR1.1341107430.840.920.77
Yi_2020FFRN/A58112930.95480.99030.9192
Yi_2021FFRN/A537101040.9630.9890.938
Author_YearReferenceOptimal MBF cut-off value (mL/min/g)TPFPFNTNAUCAUC 95% CI upper limitAUC 95% CI lower limit
Bamberg_2011FFR0.75279258N/AN/AN/A
Coenen_2017FFR0.76361012360.780.870.67
Coenen_2017_2FFR0.91491218630.85N/AN/A
Huber_2013FFR1.642207670.860.920.77
Kitagawa_2021FFR1.168292302380.840.800.87
Knegt_2021FFR0.72411981500.8629090.806
Kono_2014FFR1.0344141320.87N/AN/A
Kuwahara_2020FFR1.703742380.940.990.77
Li_2021FFR0.894932410.956N/AN/A
Lyu_2022FFR1.16170628610.8710.9260.817
Michallek_2022FFR1.16713182250.90.940.85
Nishiyama_2019FFR1.261737870.960.980.9
Nous_2022FFRN/A6223121920.790.860.71
Pontone_2019FFR1.015616151450.9190.9540.883
Rossi_2014FFR0.78491391570.950.980.92
Rossi_2017FFR1.145425181890.870.920.83
Tanabe_2020FFR1.25287532N/AN/AN/A
Yang_2020FFR1.1341107430.840.920.77
Yi_2020FFRN/A58112930.95480.99030.9192
Yi_2021FFRN/A537101040.9630.9890.938

AUC, area under the curve; CTA, computed tomography angiography; FFR, fractional flow reserve; FN, false negative; FP, false positive; MBF, myocardial blood flow; TN, true negative; TP, true positive.

Table 2

Summary of diagnostic performance of CT-MBF in included studies

Author_YearReferenceOptimal MBF cut-off value (mL/min/g)TPFPFNTNAUCAUC 95% CI upper limitAUC 95% CI lower limit
Bamberg_2011FFR0.75279258N/AN/AN/A
Coenen_2017FFR0.76361012360.780.870.67
Coenen_2017_2FFR0.91491218630.85N/AN/A
Huber_2013FFR1.642207670.860.920.77
Kitagawa_2021FFR1.168292302380.840.800.87
Knegt_2021FFR0.72411981500.8629090.806
Kono_2014FFR1.0344141320.87N/AN/A
Kuwahara_2020FFR1.703742380.940.990.77
Li_2021FFR0.894932410.956N/AN/A
Lyu_2022FFR1.16170628610.8710.9260.817
Michallek_2022FFR1.16713182250.90.940.85
Nishiyama_2019FFR1.261737870.960.980.9
Nous_2022FFRN/A6223121920.790.860.71
Pontone_2019FFR1.015616151450.9190.9540.883
Rossi_2014FFR0.78491391570.950.980.92
Rossi_2017FFR1.145425181890.870.920.83
Tanabe_2020FFR1.25287532N/AN/AN/A
Yang_2020FFR1.1341107430.840.920.77
Yi_2020FFRN/A58112930.95480.99030.9192
Yi_2021FFRN/A537101040.9630.9890.938
Author_YearReferenceOptimal MBF cut-off value (mL/min/g)TPFPFNTNAUCAUC 95% CI upper limitAUC 95% CI lower limit
Bamberg_2011FFR0.75279258N/AN/AN/A
Coenen_2017FFR0.76361012360.780.870.67
Coenen_2017_2FFR0.91491218630.85N/AN/A
Huber_2013FFR1.642207670.860.920.77
Kitagawa_2021FFR1.168292302380.840.800.87
Knegt_2021FFR0.72411981500.8629090.806
Kono_2014FFR1.0344141320.87N/AN/A
Kuwahara_2020FFR1.703742380.940.990.77
Li_2021FFR0.894932410.956N/AN/A
Lyu_2022FFR1.16170628610.8710.9260.817
Michallek_2022FFR1.16713182250.90.940.85
Nishiyama_2019FFR1.261737870.960.980.9
Nous_2022FFRN/A6223121920.790.860.71
Pontone_2019FFR1.015616151450.9190.9540.883
Rossi_2014FFR0.78491391570.950.980.92
Rossi_2017FFR1.145425181890.870.920.83
Tanabe_2020FFR1.25287532N/AN/AN/A
Yang_2020FFR1.1341107430.840.920.77
Yi_2020FFRN/A58112930.95480.99030.9192
Yi_2021FFRN/A537101040.9630.9890.938

AUC, area under the curve; CTA, computed tomography angiography; FFR, fractional flow reserve; FN, false negative; FP, false positive; MBF, myocardial blood flow; TN, true negative; TP, true positive.

Comparison of CT-MBF between regions with and without functional myocardial ischaemia

Figure 2 shows the forest plot of MBF in the region without myocardial ischaemia. The pooled MBF in the region without myocardial ischaemia was 1.39 mL/min/g [95% confidence interval (CI) 1.25–1.54, I2 = 99%, P for heterogeneity < 0.001]. Figure 3 shows a forest plot of MBF in the region where functional myocardial ischaemia was observed in the FFR. In the region of myocardial ischaemia, MBF was 0.92 mL/min/g (95% CI 0.83–1.01, I2 = 98%, P for heterogeneity < 0.001) (Figure 3). There was a statistically significant difference in pooled MBF between areas with and without functional myocardial ischaemia (P < 0.001).

Forest plot of CT-MBF in the region without functional myocardial ischaemia.
Figure 2

Forest plot of CT-MBF in the region without functional myocardial ischaemia.

Forest plot of CT-MBF in the region with functional myocardial ischaemia.
Figure 3

Forest plot of CT-MBF in the region with functional myocardial ischaemia.

Diagnostic accuracy of dynamic CTP for detection of functionally significant coronary artery stenosis

In the detection of functionally significant coronary artery stenosis as defined by FFR, the area under sROC with dynamic CT perfusion alone was 0.92 (95% CI 0.90–0.94) at the vessel level, with a sensitivity of 0.82 (95% CI 0.79–0.85) and a specificity of 0.86 (95% CI 0.84–0.88) (Figure 4). The area under sROC for diagnostic performance of coronary CTA in the analysed literature was 0.85 (95% CI 0.81–0.89) at the vessel level, with a sensitivity of 0.78 (95% CI 0.74–0.81) and specificity of 0.70 (95% CI 0.68–0.72) (see Supplementary data online, Figure S1). Area under sROC for diagnostic performance of the combination of CTA and CTP was 0.90 (95% CI 0.86–0.94) at the vessel level, sensitivity was 0.78 (95% CI 0.74–0.81) and specificity was 0.85 (95% CI 0.83–0.87) (Figure 5). The addition of CTP on CTA increased the AUC at the vessel level from 0.85 to 0.90 but was not statistically significant (P = 0.07 by χ2 test). The patient-level diagnostic performance of the combination of CTA and CTP is depicted in Supplementary data online, Figure S2, with an AUC of 0.88 (95% CI 0.82–0.94) and a pooled sensitivity of 0.83 (95% CI 0.76–0.90). The pooled sensitivity was 0.83 (95% CI 0.76–0.90), and the pooled specificity was 0.77 (95% CI 0.71–0.83).

Summary ROC and pooled sensitivity and specificity of dynamic CT perfusion to detect functionally significant coronary artery stenosis.
Figure 4

Summary ROC and pooled sensitivity and specificity of dynamic CT perfusion to detect functionally significant coronary artery stenosis.

Summary ROC and pooled sensitivity and specificity of combination of CTA and dynamic CT perfusion to detect functionally significant coronary artery stenosis.
Figure 5

Summary ROC and pooled sensitivity and specificity of combination of CTA and dynamic CT perfusion to detect functionally significant coronary artery stenosis.

Influence of CT scanner type and patient BMI on diagnostic accuracy of dynamic CT perfusion

Figure 6 compares the sROC of dynamic CTP alone with DSCT and SSCT. The AUC of DSCT was 0.92 (95% CI 0.88–0.96) and that of SSCT was 0.95 (95%CI: 0.89–1.00), and the area under sROC was similar between the two groups. The area under sROC was similar between the two groups.

Comparison of the sROC of dynamic CTP alone between DSCT and SSCT.
Figure 6

Comparison of the sROC of dynamic CTP alone between DSCT and SSCT.

Radiation exposure was 10.05 mSV (95% CI 8.35–11.75, P < 0.001, I2 = 0%, P = 0.63 for heterogeneity) in the SSCT group and 5.34 mSV (95% CI 4.14–6.55, P < 0.001, I2 = 83%, P < 0.001 for heterogeneity) in the DSCT group. DSCT was significantly less exposed than SSCT (P < 0.001). Figure 7 compares the sROC of dynamic CTP alone classified by low (<25 kg/m2) and high (≥25 kg/m2) BMI, with an AUC of 0.93 (95% CI 0.88–0.98) for low BMI and 0.92 (95% CI 0.88–0.96) for high BMI. The area under sROC was similar between the two groups.

Comparison of the sROC of dynamic CTP alone classified by low (<25 kg/m2) and high (≥25 kg/m2) BMI (vessel-based analysis).
Figure 7

Comparison of the sROC of dynamic CTP alone classified by low (<25 kg/m2) and high (≥25 kg/m2) BMI (vessel-based analysis).

Prognostic value of dynamic CT perfusion for the prediction of adverse cardiac events

Three studies showed the predictive ability of dynamic CT perfusion for cardiovascular events (Table 3). The definitions of abnormalities in dynamic CT perfusion are summarized in Table 3. Figure 8 shows the pooled heart rate (HR) of dynamic CT perfusion. A meta-analysis calculated a pooled HR of 4.98 (95% CI 2.08–11.93, P < 0.001, I2 = 61%, P for heterogeneity = 0.07).

Pooled hazard ratio of dynamic CT perfusion for the prediction of adverse cardiac events.
Figure 8

Pooled hazard ratio of dynamic CT perfusion for the prediction of adverse cardiac events.

Table 3

Summary of definitions for events and abnormal findings, and hazard ratio

Author yearDefinition of adverse eventsCut-off pointHazard ratio95% CI
Meinel_2017MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)No. of segments with perfusion defects >34.761.73–13.1
Nakamura_2020MACE (cardiac death, non-fatal myocardial infarction, unstable angina, or hospitalization for congestive heart failure)ischaemic score≧45.52.8–10.9
van Assen_2019MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)index-MBF < 0.8814.93.4–64.6
Author yearDefinition of adverse eventsCut-off pointHazard ratio95% CI
Meinel_2017MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)No. of segments with perfusion defects >34.761.73–13.1
Nakamura_2020MACE (cardiac death, non-fatal myocardial infarction, unstable angina, or hospitalization for congestive heart failure)ischaemic score≧45.52.8–10.9
van Assen_2019MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)index-MBF < 0.8814.93.4–64.6

CI, confidence interval; MACE, major adverse cardiac events; MBF, myocardial blood flow.

Table 3

Summary of definitions for events and abnormal findings, and hazard ratio

Author yearDefinition of adverse eventsCut-off pointHazard ratio95% CI
Meinel_2017MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)No. of segments with perfusion defects >34.761.73–13.1
Nakamura_2020MACE (cardiac death, non-fatal myocardial infarction, unstable angina, or hospitalization for congestive heart failure)ischaemic score≧45.52.8–10.9
van Assen_2019MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)index-MBF < 0.8814.93.4–64.6
Author yearDefinition of adverse eventsCut-off pointHazard ratio95% CI
Meinel_2017MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)No. of segments with perfusion defects >34.761.73–13.1
Nakamura_2020MACE (cardiac death, non-fatal myocardial infarction, unstable angina, or hospitalization for congestive heart failure)ischaemic score≧45.52.8–10.9
van Assen_2019MACE (cardiac death, non-fatal myocardial infarction, unstable angina requiring hospitalization, or revascularization)index-MBF < 0.8814.93.4–64.6

CI, confidence interval; MACE, major adverse cardiac events; MBF, myocardial blood flow.

Discussion

This meta-analysis illustrated the high diagnostic accuracy of dynamic CT perfusion for the detection of functional myocardial ischaemia evaluated by invasive FFR, regardless of the CT scanner, and independent of the patient's body size. Dynamic CT perfusion also exhibits significant prognostic value for patients with known or suspected CAD, making it suitable for risk stratification. These results suggest that dynamic CT perfusion might be a useful non-invasive modality for diagnosing CAD and determining treatment strategies.

Coronary CTA has been employed for non-invasive evaluation of coronary artery stenosis, demonstrating commendable diagnostic performance in excluding coronary artery conditions with acceptable radiation exposure, particularly on CT systems with 64 or more rows.34 With the introduction of a greater number of CT systems, such as 320-row systems, volumetric scanning becomes feasible, leading to a notable reduction in radiation and the potential utilization of CT for ischaemia assessment.35 Initially, the evaluation of myocardial ischaemia using CT revolved around static CT perfusion, but technological advancements have led to the adoption of dynamic CT perfusion, which offers higher accuracy. Dynamic CT perfusion surpasses myocardial SPECT in assessing myocardial ischaemia. Moreover, the simultaneous capture of coronary artery CTA and CT dynamic perfusion allows for the fusion of coronary artery anatomy and myocardial ischaemia, resulting in a more precise diagnosis of ischaemia. Numerous clinical studies and meta-analyses have been conducted in this regard. However, the recent development of DSCT demonstrates the potential to enhance the image quality of cardiac CT scans and improve quantification.36 Additionally, the gold standard for assessing ischaemia has shifted from the degree of stenosis in CAG to functional ischaemia evaluation via FFR.37 Therefore, the accuracy of MBF for ischaemia as assessed by FFR is also a matter of concern. Furthermore, obesity significantly hampers the quality of cardiac CT images,38,39 making it vital to ascertain whether the accuracy of MBF remains consistent in obese patients. With this in mind, we performed a meta-analysis to address the aforementioned questions. The results showed that dynamic CT perfusion has high diagnostic accuracy for functional myocardial ischaemia defined by invasive FFR, regardless of type of CT scanner and patients’ BMI.

Another critical role of cardiovascular imaging is to identify high-risk patients and guide them toward appropriate treatment, known as risk stratification. Our meta-analysis was conducted due to the presence of three articles reporting hazard ratios for dynamic CT perfusion in relation to cardiovascular events. The results revealed that dynamic CT perfusion holds significant prognostic value, as indicated by a pooled hazard ratio of 4.98. When combined with coronary CTA findings, this risk stratification can be further strengthened. Thus, intensive preventive measures may be recommended not only for patients with coronary plaque identified on coronary CTA but also for individuals exhibiting minimal atherosclerotic changes on coronary CTA yet demonstrating high-risk indicators on myocardial perfusion. These aspects should be clarified through future studies.

Several limitations exist within this study. Firstly, heterogeneity in CT-MBF values has been observed. This disparity could stem from variations in imaging methodologies or patient characteristics, although the precise reasons remain unclear and necessitate careful interpretation. Secondly, only a limited number of papers have presented prognostic predictions, and the definition of events varies across studies. Therefore, it is desirable to conduct more diverse prospective studies in the future.

Conclusions

Dynamic CT perfusion exhibits a high diagnostic capability in the quantitative assessment of ischaemia and the identification of functionally significant coronary artery stenosis. These observations remain consistent regardless of the specific CT scanner employed or the patient's BMI. Moreover, dynamic CT perfusion holds promise as a valuable tool for risk stratification among individuals diagnosed with CAD. These results suggest that dynamic CT perfusion might be a useful non-invasive modality for diagnosing CAD and determining treatment strategies.

Supplementary data

Supplementary data are available at European Heart Journal - Cardiovascular Imaging online.

Funding

None declared.

Data availability

The data underlying this article will be shared upon reasonable request from the corresponding authors.

References

1

Brown
 
JC
,
Gerhardt
 
TE
,
Kwon
 
E
. Risk factors for coronary artery disease. In:
StatPearls
.
Treasure Island (FL)
:
StatPearls Publishing LLC
;
2023
.

2

Schinkel
 
AF
,
Elhendy
 
A
,
Van Domburg
 
RT
,
Bax
 
JJ
,
Valkema
 
R
,
Roelandt
 
JR
 et al.  
Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up
.
Radiology
 
2002
;
225
:
701
6
.

3

Hachamovitch
 
R
,
Hayes
 
SW
,
Friedman
 
JD
,
Cohen
 
I
,
Berman
 
DS
.
Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography
.
Circulation
 
2003
;
107
:
2900
7
.

4

Li
 
Y
,
Yu
 
M
,
Dai
 
X
,
Lu
 
Z
,
Shen
 
C
,
Wang
 
Y
 et al.  
Detection of hemodynamically significant coronary stenosis: CT myocardial perfusion versus machine learning CT fractional flow reserve
.
Radiology
 
2019
;
293
:
305
14
.

5

Nous
 
FMA
,
Geisler
 
T
,
Kruk
 
MBP
,
Alkadhi
 
H
,
Kitagawa
 
K
,
Vliegenthart
 
R
 et al.  
Dynamic myocardial perfusion CT for the detection of hemodynamically significant coronary artery disease
.
JACC Cardiovasc Imaging
 
2022
;
15
:
75
87
.

6

Celeng
 
C
,
Leiner
 
T
,
Maurovich-Horvat
 
P
,
Merkely
 
B
,
de Jong
 
P
,
Dankbaar
 
JW
 et al.  
Anatomical and functional computed tomography for diagnosing hemodynamically significant coronary artery disease: a meta-analysis
.
JACC Cardiovasc Imaging
 
2019
;
12
(
7 Pt 2
):
1316
25
.

7

Kitagawa
 
K
,
Nakamura
 
S
,
Ota
 
H
,
Ogawa
 
R
,
Shizuka
 
T
,
Kubo
 
T
 et al.  
Diagnostic performance of dynamic myocardial perfusion imaging using dual-source computed tomography
.
J Am Coll Cardiol
 
2021
;
78
:
1937
49
.

8

Lu
 
M
,
Wang
 
S
,
Sirajuddin
 
A
,
Arai
 
AE
,
Zhao
 
S
.
Dynamic stress computed tomography myocardial perfusion for detecting myocardial ischemia: a systematic review and meta-analysis
.
Int J Cardiol
 
2018
;
258
:
325
31
.

9

Page
 
MJ
,
McKenzie
 
JE
,
Bossuyt
 
PM
,
Boutron
 
I
,
Hoffmann
 
TC
,
Mulrow
 
CD
 et al.  
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
.
BMJ
 
2021
;
372
:
n71
.

10

Whiting
 
PF
,
Rutjes
 
AW
,
Westwood
 
ME
,
Mallett
 
S
,
Deeks
 
JJ
,
Reitsma
 
JB
 et al.  
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
.
Ann Intern Med
 
2011
;
155
:
529
36
.

11

Leeflang
 
MM
,
Deeks
 
JJ
,
Gatsonis
 
C
,
Bossuyt
 
PM
.
Systematic reviews of diagnostic test accuracy
.
Ann Intern Med
 
2008
;
149
:
889
97
.

12

Higgins
 
JP
,
Thompson
 
SG
.
Quantifying heterogeneity in a meta-analysis
.
Stat Med
 
2002
;
21
:
1539
58
.

13

Bamberg
 
F
,
Becker
 
A
,
Schwarz
 
F
,
Marcus
 
RP
,
Greif
 
M
,
von Ziegler
 
F
 et al.  
Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging
.
Radiology
 
2011
;
260
:
689
98
.

14

Coenen
 
A
,
Lubbers
 
MM
,
Kurata
 
A
,
Kono
 
A
,
Dedic
 
A
,
Chelu
 
RG
 et al.  
Diagnostic value of transmural perfusion ratio derived from dynamic CT-based myocardial perfusion imaging for the detection of haemodynamically relevant coronary artery stenosis
.
Eur Radiol
 
2017
;
27
:
2309
16
.

15

Coenen
 
A
,
Rossi
 
A
,
Lubbers
 
MM
,
Kurata
 
A
,
Kono
 
AK
,
Chelu
 
RG
 et al.  
Integrating CT myocardial perfusion and CT-FFR in the work-up of coronary artery disease
.
JACC Cardiovasc Imaging
 
2017
;
10
:
760
70
.

16

de Knegt
 
MC
,
Rossi
 
A
,
Petersen
 
SE
,
Wragg
 
A
,
Khurram
 
R
,
Westwood
 
M
 et al.  
Stress myocardial perfusion with qualitative magnetic resonance and quantitative dynamic computed tomography: comparison of diagnostic performance and incremental value over coronary computed tomography angiography
.
Eur Heart J Cardiovasc Imaging
 
2021
;
22
:
1452
62
.

17

Huber
 
AM
,
Leber
 
V
,
Gramer
 
BM
,
Muenzel
 
D
,
Leber
 
A
,
Rieber
 
J
 et al.  
Myocardium: dynamic versus single-shot CT perfusion imaging
.
Radiology
 
2013
;
269
:
377
85
.

18

Kono
 
T
,
Uetani
 
T
,
Inoue
 
K
,
Nagai
 
T
,
Nishimura
 
K
,
Suzuki
 
J
 et al.  
Diagnostic accuracy of stress myocardial computed tomography perfusion imaging to detect myocardial ischemia: a comparison with coronary flow velocity reserve derived from transthoracic Doppler echocardiography
.
J Cardiol
 
2020
;
76
:
251
8
.

19

Kuwahara
 
N
,
Tanabe
 
Y
,
Kido
 
T
,
Kurata
 
A
,
Uetani
 
T
,
Ochi
 
H
 et al.  
Coronary artery stenosis-related perfusion ratio using dynamic computed tomography myocardial perfusion imaging: a pilot for identification of hemodynamically significant coronary artery disease
.
Cardiovasc Interv Ther
 
2020
;
35
:
327
35
.

20

Li
 
Y
,
Dai
 
X
,
Lu
 
Z
,
Shen
 
C
,
Zhang
 
J
.
Diagnostic performance of quantitative, semi-quantitative, and visual analysis of dynamic CT myocardial perfusion imaging: a validation study with invasive fractional flow reserve
.
Eur Radiol
 
2021
;
31
:
525
34
.

21

Lyu
 
L
,
Pan
 
J
,
Li
 
D
,
Li
 
X
,
Yang
 
W
,
Dong
 
M
 et al.  
Knowledge of hyperemic myocardial blood flow in healthy subjects helps identify myocardial ischemia in patients with coronary artery disease
.
Front Cardiovasc Med
 
2022
;
9
:
817911
.

22

Michallek
 
F
,
Nakamura
 
S
,
Kurita
 
T
,
Ota
 
H
,
Nishimiya
 
K
,
Ogawa
 
R
 et al.  
Fractal analysis of dynamic stress CT-perfusion imaging for detection of hemodynamically relevant coronary artery disease
.
JACC Cardiovasc Imaging
 
2022
;
15
:
1591
601
.

23

Nishiyama
 
H
,
Tanabe
 
Y
,
Kido
 
T
,
Kurata
 
A
,
Uetani
 
T
,
Kido
 
T
 et al.  
Incremental diagnostic value of whole-heart dynamic computed tomography perfusion imaging for detecting obstructive coronary artery disease
.
J Cardiol
 
2019
;
73
:
425
31
.

24

Pontone
 
G
,
Baggiano
 
A
,
Andreini
 
D
,
Guaricci
 
AI
,
Guglielmo
 
M
,
Muscogiuri
 
G
 et al.  
Dynamic stress computed tomography perfusion with a whole-heart coverage scanner in addition to coronary computed tomography angiography and fractional flow reserve computed tomography derived
.
JACC Cardiovasc Imaging
 
2019
;
12
:
2460
71
.

25

Rossi
 
A
,
Dharampal
 
A
,
Wragg
 
A
,
Davies
 
LC
,
van Geuns
 
RJ
,
Anagnostopoulos
 
C
 et al.  
Diagnostic performance of hyperaemic myocardial blood flow index obtained by dynamic computed tomography: does it predict functionally significant coronary lesions?
 
Eur Heart J Cardiovasc Imaging
 
2014
;
15
:
85
94
.

26

Rossi
 
A
,
Wragg
 
A
,
Klotz
 
E
,
Pirro
 
F
,
Moon
 
JC
,
Nieman
 
K
 et al.  
Dynamic computed tomography myocardial perfusion imaging: comparison of clinical analysis methods for the detection of vessel-specific ischemia
.
Circ Cardiovasc Imaging
 
2017
;
10
:
e005505
.

27

Tanabe
 
Y
,
Kido
 
T
,
Kurata
 
A
,
Uetani
 
T
,
Kuwahara
 
N
,
Morikawa
 
T
 et al.  
Combined assessment of subtended myocardial volume and myocardial blood flow for diagnosis of obstructive coronary artery disease using cardiac computed tomography: a feasibility study
.
J Cardiol
 
2020
;
76
:
259
65
.

28

Yang
 
J
,
Dou
 
G
,
He
 
B
,
Jin
 
Q
,
Chen
 
Z
,
Jing
 
J
 et al.  
Stress myocardial blood flow ratio by dynamic CT perfusion identifies hemodynamically significant CAD
.
JACC Cardiovasc Imaging
 
2020
;
13
:
966
76
.

29

Yi
 
Y
,
Xu
 
C
,
Wu
 
W
,
Shen
 
ZJ
,
Lee
 
W
,
Yun
 
CH
 et al.  
Low-dose CT perfusion with combined use of CTP and CTP-derived coronary CT angiography at 70 kVp: validation with invasive fractional flow reserve
.
Eur Radiol
 
2021
;
31
:
1119
29
.

30

Yi
 
Y
,
Xu
 
C
,
Wu
 
W
,
Wang
 
Y
,
Li
 
YM
,
Shen
 
ZJ
 et al.  
Myocardial blood flow analysis of stress dynamic myocardial CT perfusion for hemodynamically significant coronary artery disease diagnosis: the clinical value of relative parameter optimization
.
J Cardiovasc Comput Tomogr
 
2020
;
14
:
314
21
.

31

Meinel
 
FG
,
Pugliese
 
F
,
Schoepf
 
UJ
,
Ebersberger
 
U
,
Wichmann
 
JL
,
Lo
 
GG
 et al.  
Prognostic value of stress dynamic myocardial perfusion CT in a multicenter population with known or suspected coronary artery disease
.
Am J Roentgenol
 
2017
;
208
:
761
9
.

32

Nakamura
 
S
,
Kitagawa
 
K
,
Goto
 
Y
,
Takafuji
 
M
,
Nakamori
 
S
,
Kurita
 
T
 et al.  
Prognostic value of stress dynamic computed tomography perfusion with computed tomography delayed enhancement
.
JACC Cardiovasc Imaging
 
2020
;
13
:
1721
34
.

33

van Assen
 
M
,
De Cecco
 
CN
,
Eid
 
M
,
Doeberitz
 
PV
,
Scarabello
 
M
,
Lavra
 
F
 et al.  
Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease
.
J Cardiovasc Comput Tomogr
 
2019
;
13
:
26
33
.

34

Miller
 
JM
,
Rochitte
 
CE
,
Dewey
 
M
,
Arbab-Zadeh
 
A
,
Niinuma
 
H
,
Gottlieb
 
I
 et al.  
Diagnostic performance of coronary angiography by 64-row CT
.
N Engl J Med
 
2008
;
359
:
2324
36
.

35

Rochitte
 
CE
,
George
 
RT
,
Chen
 
MY
,
Arbab-Zadeh
 
A
,
Dewey
 
M
,
Miller
 
JM
 et al.  
Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study
.
Eur Heart J
 
2014
;
35
:
1120
30
.

36

Danad
 
I
,
Fayad
 
ZA
,
Willemink
 
MJ
,
Min
 
JK
.
New applications of cardiac computed tomography: dual-energy, spectral, and molecular CT imaging
.
JACC Cardiovasc Imaging
 
2015
;
8
:
710
23
.

37

Tonino
 
PA
,
De Bruyne
 
B
,
Pijls
 
NH
,
Siebert
 
U
,
Ikeno
 
F
,
van’ t Veer
 
M
 et al.  
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
.
N Engl J Med
 
2009
;
360
:
213
24
.

38

Szucs-Farkas
 
Z
,
Verdun
 
FR
,
von Allmen
 
G
,
Mini
 
RL
,
Vock
 
P
.
Effect of X-ray tube parameters, iodine concentration, and patient size on image quality in pulmonary computed tomography angiography: a chest-phantom-study
.
Invest Radiol
 
2008
;
43
:
374
81
.

39

Schindera
 
ST
,
Tock
 
I
,
Marin
 
D
,
Nelson
 
RC
,
Raupach
 
R
,
Hagemeister
 
M
 et al.  
Effect of beam hardening on arterial enhancement in thoracoabdominal CT angiography with increasing patient size: an in vitro and in vivo study
.
Radiology
 
2010
;
256
:
528
35
.

Author notes

Conflict of interest: None declared.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)

Supplementary data